Inflame Applian. (541083)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Revenue growth of 43.49% and profit growth of 334.57% show strong recent momentum.
• Piotroski F-Score of 7/9 suggests reasonable fundamental health on the available metrics.
• PEG ratio of 0.20 indicates the growth rate could outweigh the earnings multiple if sustained.
• Latest quarter remains profitable: sales ₹76 Cr and net profit ₹4 Cr.

Concerns

• P/E of 38.21 is expensive; limited margin of safety at ₹431.30 near 52-week high.
• Missing ROE, book value, and debt/equity data prevent a full assessment of financial strength.
• ROCE of 8.55% is mediocre, suggesting no strong durable competitive advantage yet.
• No dividend means total return depends entirely on future price appreciation.

AI Analysis

I have always told shareholders that a good investment combines a simple business, strong fundamentals, and a sensible price. Inflame Appliances operates in houseware, which I can understand. The growth figures are eye-catching: sales up 43.49% and profits up 334.57%. But a 334% profit rise from a small base does not prove durability. The latest quarter had sales of ₹76 Cr and net profit of ₹4 Cr, so the net margin is only around 5%. At a P/E of 38.21, the market is paying a rich price for this. I cannot compute ROE, book value, or debt-to-equity because the data are missing, and without those I cannot judge financial health properly. ROCE of 8.55% is moderate and does not signal a wide moat. The Piotroski F-Score of 7/9 is encouraging, but it does not fill the gaps in disclosure. The PEG ratio of 0.20 looks attractive only if 43% sales growth continues for years. Also, there is no dividend, so the entire investment case is capital appreciation. The stock trades at ₹431.30, near the top of its 52-week range of ₹187.10-₹431.30. Graham taught me to buy with a margin of safety. Here, the safety net is thin because key metrics are unavailable. I will watch from the sidelines until profitability, return on capital, and balance-sheet strength are proven over several quarters. This is a potential fast grower, but potential is not purchase.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer